As of September 2024, Shin Nippon Biomedical Laboratories has a market cap of $345.51M. This makes Shin Nippon Biomedical Laboratories the world's 13783th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $475.55M | -5.24% |
2023 | $501.86M | -24.87% |
2022 | $667.96M | 59.15% |
2021 | $419.69M | 110.37% |
2020 | $199.50M | 6.97% |
2019 | $186.50M | -5.82% |
2018 | $198.02M | 15.72% |
2017 | $171.13M | -1.19% |
2016 | $173.20M | 41.20% |
2015 | $122.66M | -47.53% |
2014 | $233.79M | -40.75% |
2013 | $394.57M | 326.52% |
2012 | $92.51M | 59.69% |
2011 | $57.93M | -49.22% |
2010 | $114.09M | -29.82% |
2009 | $162.56M | -22.32% |
2008 | $209.26M | -58.43% |
2007 | $503.34M | -20.61% |
2006 | $633.97M | 9.94% |
2005 | $576.64M | 390.82% |
2004 | $117.48M | - |